Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-16-155516

SVP & Chief Scientific Officer acquired 17,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Doberstein Stephen K · SVP & Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2016-12-13 Grant or award : show line 1 in the form +17,500 35,765 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-12-13 Grant or award : show line 2 in the form Stock Option +43,750 $12.24 2024-12-12 43,750 43,750 D
Loading xslF345X03/doc4.xml…